Policy Developments - Shenzhen has issued measures to support the development of innovative drugs and medical devices, focusing on areas such as nucleic acid drugs, protein and peptide drugs, cell drugs, and small molecule innovative drugs, with a total of 32 specific measures proposed [1] Drug Approvals - Eli Lilly's application for the new drug imlunestrant, a selective estrogen receptor degrader for treating ER+ and HER2- advanced breast cancer, has been accepted by China's National Medical Products Administration [2] - Heng Rui Medicine's SHR0302 (aimatinib), a JAK1 inhibitor, has received approval for a new indication for treating moderate to severe atopic dermatitis in adults and adolescents aged 12 and above [3] Capital Market Activities - Kehua Bio has signed an investment cooperation agreement to establish a medical device and testing reagent production base and an innovation center in Xi'an, covering approximately 90 acres [4] - TianKang Bio plans to introduce external investors through a capital increase, with two investors subscribing to a total of RMB 27.5 million for new registered capital [6] Research and Development - Innovent Biologics has announced that its tumor pipeline products ICP-248, ICP-723, and ICP-B05 have been selected for presentation at the 2025 ASCO Annual Meeting [5] - Pian Zai Huang has signed a technology transfer contract worth RMB 13.58 million for a new traditional Chinese medicine, which aligns with the trend of innovation in the TCM industry [8] Financial Reports - Sunshine Nuohua reported a revenue of RMB 1.078 billion for 2024, a year-on-year increase of 15.7%, but a net profit of RMB 177 million, down 3.98% [9] - David Medical's revenue for 2024 was RMB 527.03 million, a decrease of 14.76%, with a net profit decline of 61.21% [10] - Bai O Tai reported a revenue of RMB 743 million for 2024, a 5.44% increase, but a net loss of RMB 510 million, compared to a loss of RMB 395 million in the previous year [11]

金十数据整理：每日美股市场要闻速递（4月8日 周二） 重要新闻 个股新闻 1. 美联储古尔斯比表示，企业担心关税将重新引发通胀飙升。 2. 美国财长贝森特表示，美国总统特朗普将亲自参与贸易谈判。 3. 消息人士：美国总统特朗普将于周二签署行政命令，以支持煤炭行业。 1. 博通(AVGO.O)宣布100亿美元股票回购计划。 2. 联电(UMC.N)3月营收同比增长9.31%至198.6亿新台币。 3. 微牛公司赴美IPO获中国证监会备案，拟发行约6422万股。 4. 礼来(LLY.N)1类新药imlunestrant片在中国上市申请获受理，治疗乳腺癌。 5. 苹果(AAPL.O)的工作人员报告称，上周末有大批顾客恐慌性购买苹果产品。 6. 通用汽车(GM.N)发布新款纯电动科尔维特概念车，重申对欧洲市场发展承诺。 7. 美光科技(MU.O)告诉美国客户，将从4月9日起对部分产品征收与关税相关的附加费。 8. 联合健康(UNH.N)美股盘后上涨5%，特朗普政府将在明年大幅提高医疗保险支付费率。 ...